SBI Healthcare Opportunities Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹2011 Cr | ₹4131 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.14 | 1.94 |
| Manager | Dhruv Muchhal | Pradeep Kesavan |
| ISIN Code | INF179KC1HL7 | INF200K01446 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | -0.5% | -2.03% |
| 6 Month | 5.66% | 1.18% |
| 1 Year | 4.39% | -1.08% |
| 3 Year | - | 23.94% |
| 5 Year | - | 16.56% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | -1.12% | -2.98% |
| 1 Year | 7.48% | 0.04% |
| 3 Year | - | 17.53% |
| 5 Year | - | 18.19% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 27.59% | 15.23% |
| 3 Year | - | 18.03% |
| 5 Year | - | 13.3% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | - | 14.02% |
| Sharp | - | 1.2% |
| Beta | - | 0.8% |
| Alpha | - | 4.66% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Dhruv Muchhal | Pradeep Kesavan |
| Total AUM | ₹520687 Cr | ₹434274 Cr |
| Funds Managed | 40 | 43 |
| HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 10.4 | 14.91 |
| Mid Cap | 30.37 | 26.97 |
| Small Cap | 32.94 | 31.19 |
| Large Cap | 26.28 | 26.92 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.62 | 4.18 |
| Basic Materials | 2.97 | 6.98 |
| Healthcare | 95.41 | 88.84 |
Top Comparisons
Aditya Birla Sun Life Multi-Cap Fund-Regular Growth
3Y Returns18.16%
Mirae Asset Multicap Fund - Regular (G)
3Y Returns0%
Bandhan Large & Mid Cap Fund - Regular Plan - Growth
3Y Returns24.74%
Axis Large & Mid Cap Fund - Regular Plan - Growth
3Y Returns20.68%
Bandhan Gilt Fund - Regular Plan - Growth
3Y Returns7%
Baroda BNP Paribas GILT FUND - Regular Plan - Growth Option
3Y Returns7.45%
ICICI Prudential Equity & Debt Fund - Growth
3Y Returns20.11%
UTI Aggressive Hybrid Fund- Regular Plan - Growth
3Y Returns17.65%